How the NIH is Changing Its Grant Approval Process

The National Institutes of Health is reshaping how it evaluates and funds scientific research. The changes fall into two parts: a simplified review process designed to make decisions faster, and a shift toward greater political oversight of which projects get funded.

What Changed in the Review Process

For decades, the NIH used a detailed checklist when evaluating grant applications. Peer reviewers — other scientists in the field — would score proposals on separate dimensions: Was the question significant? Was the approach innovative? Were the researchers qualified? Each score mattered separately.

In March 2025, the NIH moved to a simpler system. Now, reviewers provide a single overall score that captures whether they think a project will meaningfully advance the field. The stated goal is to cut through what the agency saw as unnecessary complexity and reduce the chance that unconscious bias about a researcher's reputation might skew the outcome.

This isn't the NIH's first attempt at modernization. In 2022, the agency floated this simplified framework for public comment. Earlier reforms included a 2020 requirement that researchers write out detailed data-sharing plans, and a 2016 push to use single ethics review boards across multi-site studies rather than letting each institution have its own.

Political Oversight Enters the Picture

The peer review changes alone might have been routine administrative housekeeping. But they coincide with something more significant: a new layer of political control over what gets funded.

In August 2025, President Donald Trump signed an executive order allowing political appointees to cancel federal grants — including scientific ones — if they don't match agency priorities. The accompanying guidance told senior officials that they should not automatically rubber-stamp what peer reviewers recommend. For eight decades, that rubber-stamp deference has been the foundation of federal science funding.

Current and former NIH officials have raised concerns about this shift. The worry is straightforward: political appointees could now reject projects that deserve funding by traditional scientific standards, or approve favored projects that wouldn't normally qualify. That breaks the meritocratic model that has guided federal research support since World War II.

What the Inspector General Found

The HHS Office of Inspector General — an independent watchdog — recently audited how the NIH makes funding decisions. The report flagged a problem: when the NIH funds applications out of the normal ranked order (which does happen sometimes), the agency doesn't always clearly track why or keep transparent records.

The Inspector General recommended that NIH create a central system to monitor these exceptions and document the reasoning. The timing of this finding is worth noting. It underscores questions about decision-making transparency at a moment when political considerations are becoming part of the equation.

The Broader Context

This isn't the first time political pressure has threatened the independence of peer review in science. In the 1970s, the scientific community pushed back against government interference and successfully protected the peer review system. What's different now is the scale and speed: these are the most substantial changes to federal research funding since the modern grant system took shape in the post-war decades.

Congress has been watching. The House Energy and Commerce Committee held hearings throughout 2024 and into 2025 examining NIH operations, grant management, and how the agency oversees its decision-making. That sustained attention provided the political backdrop for the changes now being rolled out.

What This Means for Scientists and Universities

The practical effect is new uncertainty for researchers. Universities and principal investigators are trying to figure out how the streamlined review and political oversight will affect their prospects.

Streamlining the review form itself could be a genuine efficiency gain — fewer boxes to check might mean faster decisions. But the introduction of political considerations into funding choices marks a significant shift from the merit-based approach that has governed federal science investment for nearly eighty years.

Research teams will need to adapt to centralized review mechanisms while wondering whether their work aligns with current political priorities. Institutions must prepare for a funding environment where scientific quality remains important, but is no longer the sole arbiter of success.

What Happens Next

The effects of this new system will unfold over time. Whether these changes strengthen or weaken the scientific enterprise will depend on how they work in practice. The research community will be watching closely — not out of ideology, but because federal funding supports roughly half of all basic research in the United States. When the rules change, everything downstream changes with it.